Pfizer says kid-size doses of its COVID-19 vaccine are safe and nearly 91% effective at preventing symptomatic infections in elementary schoolchildren. Details of the study were posted online Friday as U.S. regulators consider opening vaccinations to youngsters 5 to 11. NJ Gov touts accomplishments ahead of election.